author-photo

Naiara Martínez-Vélez

University of Navarra

48

Papers

239

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
IMMU-39. TIM-3 APTAMER IN COMBINATION WITH RADIOTHERAPY RESULTS IN ENHANCED SURVIVAL IN DIPG MODELS

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs

2020 Clinical & Biomedical Research
Show All
- Source
- Cite
- Save
Citations (1)
IMMU-14. ONCOLYTIC ADENOVIRUS DELTA-24-RGD ENGINEERED TO EXPRESS 4-1BBL AS A THERAPEUTIC APPROACH FOR DIPG

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Local administration of interleukin-12 with a high-capacity vector results in local and metastatic tumor control in pediatric osteosarcoma

2020 Molecular Therapy - Oncolytics
Show All
- Source
- Cite
- Save
Citations (0)
THER-01. AWAKING THE IMMUNE SYSTEM WITH AN IMMUNO-ONCOLYTIC VIRUS AS A THERAPEUTIC STRATEGY FOR DIPGs

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
DIPG-04. TRANSLATION OF DNX-2401 FROM THE BENCH TO THE CLINIC FOR PEDIATRIC HIGH GRADE GLIOMAS INCLUDING DIFFUSE INTRINSIC PONTINE GLIOMAS

2019 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

2019 Nature Communications
Show All
- Source
- Cite
- Save
Citations (46)
Abstract 3117: Delta-24-RGD/DNX-2401: Oncolytic virotherapy for pediatric high grade glioma and DIPG

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (7)